| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Febbo Phillip G. | Chief Scientific & Med Officer | 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO | /s/ Jonathan Wygant, as attorney-in-fact | 04 Sep 2025 | 0001649245 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VCYT | Common Stock | Tax liability | $88,975 | -2,955 | -2.8% | $30.11 | 100,790 | 02 Sep 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2025 and does not represent a sale. |